Rong Cao
Chinese Academy of Sciences
624 Papers
5.8K Citations
Rong Cao is an academic researcher from Chinese Academy of Sciences. The author has contributed to research in topics: Chemistry & Catalysis. The author has an hindex of 76, co-authored 568 publications. Previous affiliations of Rong Cao include Hefei University of Technology & University of Science and Technology of China.
Chat about Author
Papers
Multifunctional metal–organic framework catalysts: synergistic catalysis and tandem reactions
TL;DR: In this review, the applications of MOFs with multiple active sites in synergistic organic catalysis, photocatalysis and tandem reactions are discussed and proposed mechanisms are presented in detail.
1.7K
Metal–organic frameworks based on flexible ligands (FL-MOFs): structures and applications
TL;DR: In this review, emphasis has been placed on the design and the structural diversity of FL-MOFs and dynamic frameworks induced by flexible ligands are briefly outlined.
843
Highly Selective CO 2 Electroreduction to CH 4 by In Situ Generated Cu 2 O Single-Type Sites on a Conductive MOF: Stabilizing Key Intermediates with Hydrogen Bonding
Jun-Dong Yi,Ruikuan Xie,Zai-Lai Xie,Guo-Liang Chai,Tian-Fu Liu,Rui-Ping Chen,Yuan-Biao Huang,Rong Cao +7 more
TL;DR: Operando infrared spectroscopy and density functional theory (DFT) calculations reveal that the key intermediates involved in the formation CH 4 pathway are stabilized by the single active Cu 2 O(111) and hydrogen bonding, thus generating CH 4 instead of CO.
414
Metal–organic frameworks and porous organic polymers for sustainable fixation of carbon dioxide into cyclic carbonates
TL;DR: In this paper, the synthesis and catalytic performances of various kinds of newly developed porous heterogeneous catalysts with Lewis acidic and nucleophilic sites are described from the perspective of catalyst design.
401
An Ultra-Robust and Crystalline Redeemable Hydrogen-Bonded Organic Framework for Synergistic Chemo-Photodynamic Therapy
TL;DR: PFC-1 can efficiently encapsulate Doxorubicin for synergistic chemo-photodynamic therapy, showing comparable therapeutic efficacy with the commercial Doxo yet considerably lower cytotoxicity.
380